Tag: AbbVie
The Pharmaceutical Accountability Foundations’ Excessive Pricing Case Against AbbVie Heads to Court 9 May
Farma ter Verantwoording -
AMSTERDAM, THE NETHERLANDS: In February 2023, the Pharmaceutical Accountability Foundation (PAF) filed a lawsuit against AbbVie Netherlands and AbbVie Inc (globally), alleging that the...
Friday, May 9 (09:30-12:30), Farma ter Verantwoording and AbbVie will meet at the Amsterdam District Court, Parnassusweg 280, 1076 AV Amsterdam (near Amsterdam Zuid...
The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira
Wilbert Bannenberg -
The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to...
PRESS RELEASE: Lawsuit against AbbVie for abuse of economic dominance and violation of human rights moves to substantive phase
Farma ter Verantwoording -
AbbVie's Humira pricing policy drained up to €1.2 billion from the Dutch healthcare system
AMSTERDAM, NETHERLANDS: Today the Amsterdam District Court ruled that the lawsuit...
The Pharmaceutical Accountability Foundation faces AbbVie in Court for the first time in its Humira pricing case
Rosalind Turkie -
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros
Rosalind Turkie -
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
Version 15 November 2023
About Adalimumab/Humira and pricing issues
AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the...
Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie
Rosalind Turkie -
Download the original (Dutch) here:
antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload
Download the English translation here:
Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload
The Pharmaceutical Accountability Foundation recently launched a court case against pharma-giant AbbVie for excessive pricing of blockbuster drug Humira (adalimumab). We received media attention...
AbbVie overcharged the Dutch health care system by as much as €1.2 billion for Humira
Rosalind Turkie -
AMSTERDAM, THE NETHERLANDS: The Pharmaceutical Accountability Foundation (PAF) today brought a lawsuit against pharmaceutical company AbbVie for unfair, excessive pricing practices on its blockbuster...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022